Nolan Family Center for Cardiovascular Health
Resources for Professionals
Cardiovascular Prevention Research Fellowship
Training in cardiovascular prevention is suboptimal. With our large population of prevention patients and excellent research opportunities, MHIF offers a high-quality, one-year fellowship training program in cardiovascular prevention for physicians. More information
Cardiovascular Prevention Symposium
Each year, the Minneapolis Heart Institute® Cardiovascular Prevention Program sponsors a symposium on cardiovascular disease prevention for health professionals. Watch this short video with highlights from our 2019 Symposium.
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Dr. Michael Miedema, director of the Nolan Family Center for Cardiovascular Health at Minneapolis Heart Institute Foundation, was a member of the 2019 ACC/AHA Committee for the Primary Prevention of CVD Guidelines.
Recent Prevention Publications
MHIF’s prevention team has authored hundreds of papers and presents frequently at national and international conferences. Read some of the latest publications from our team below.
Oct 2020: Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)
Recent articles from The Coronary Artery Calcium (CAC) Consortium: The Coronary Artery Calcium Consortium is a multi-center observational cohort study from four clinical centers, including the Minneapolis Heart Institute Foundation, linked to long-term follow-up for cause-specific mortality. The CAC Consortium is large and highly generalizable data set that is uniquely positioned to expand the understanding of CAC as a predictor of mortality risk across the spectrum of disease states, allowing innovative modeling of the competing risks of cardiovascular and non-cardiovascular death.
Kevin Graham Prevention Lecture
This annual lecture honors the work of Dr. Kevin J. Graham and features international leaders in the field of cardiovascular prevention. A tireless and innovative thought leader in cardiology, Dr. Graham served as president of the Minneapolis Heart Institute® and the Cardiovascular Services Division of Abbott Northwestern Hospital from 2007 to 2012. He established and led the Preventive Cardiology practice and was Director of Outpatient Clinical Laboratory at the Minneapolis Heart Institute®. Past lectures:
October 28, 2019 • Kevin Graham Prevention Lecture – Food is Medicine: Dietary and Policy Priorities for Cardiometabolic Health by Dariush Mozaffarian, MD, DrPH; Dean, Friedman School of Nutrition Science & Policy at Tufts University (Slides) (Recording)
October 22, 2018 • Kevin Graham Prevention Lecture: Precision cardiovascular prevention: past, present, and future by Philip Greenland, MD, Harry W. Dingman Professor of Cardiology and Professor of Preventive Medicine, Northwestern University Feinberg School of Medicine (Slides) (Recording)
Prevention Lectures from MHIF Grand Rounds
Watch recordings or view slides from past lectures on cardiovascular disease prevention and related topics.
April 5, 2021 • A 2021 Cardiovascular Prevention Update by Courtney Jordan Baechler, MD, MS; Thomas Knickelbine, MD, FACC, FSCAI, FSCCT; Michael Miedema, MD, MPH; Elizabeth Tuohy, MD (Slides) (Recording)
November 9, 2020 • AHA Preview: Predicted Versus Observed 10-year Cardiovascular Event Rates in a Rural Population-based Health Program: The Heart of New Ulm Project by Angela Phillips, DO (Slides) (Recording)
October 26, 2020 • Equity in Cardiovascular Health Outcomes—Facts, Figures, and MHI Strategies to Close the Gap by Courtney Jordan Baechler, MD; Mosi Bennett, MD, PhD; Mario Gössl, MD, PhD (Slides) (Recording)
November 5, 2018 • 2018 AHA Scientific Sessions PREVIEW
Statin Eligibility and Prevalence of Statin Prescriptions According to the 2013 American College of Cardiology – American Heart Association Cholesterol Guidelines in a Large Multi-Center Healthcare System by Joseph C. Jensen, MD. (Slides) (Recording)
March 5, 2018 • ACC Scientific Sessions Preview (Slides) (Recording)
PCSK9 Inhibitors in Patients With Familial Hypercholesterolemia and/or CVD: The Impact of a Systematic, Team-Based Approach to Prescription on Rates of Insurance Approval and Lipid Lowering by Thomas Knickelbine, MD